Evidence map›Paper›PMID 41990387›Full record

ReviewAnnual review of neuroscience2026

Path Integration in Alzheimer's Disease: Orientation, Movement, and Theta Rhythmicity.

Andrea Castegnaro, Misun Kim, Katarzyna Rudzka, Neil Burgess

Abstract readReview
In one paragraph

Review in Annual review of neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrea CastegnaroUCL Institute of Cognitive Neuroscience, University College London, London, United Kingdom; email: andrea.castegnaro.15@ucl.ac.uk, misun.kim@ucl.ac.uk, n.burgess@ucl.ac.uk.
Misun KimUCL Institute of Cognitive Neuroscience, University College London, London, United Kingdom; email: andrea.castegnaro.15@ucl.ac.uk, misun.kim@ucl.ac.uk, n.burgess@ucl.ac.uk.
Katarzyna RudzkaUCL Institute of Cognitive Neuroscience, University College London, London, United Kingdom; email: andrea.castegnaro.15@ucl.ac.uk, misun.kim@ucl.ac.uk, n.burgess@ucl.ac.uk.
Neil BurgessUCL Institute of Cognitive Neuroscience, University College London, London, United Kingdom; email: andrea.castegnaro.15@ucl.ac.uk, misun.kim@ucl.ac.uk, n.burgess@ucl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Path integration (PI), the ability to keep track of position and orientation from self-motion, is a sensitive cognitive marker of Alzheimer's disease. While entorhinal grid cells are central to PI, we focus here on the broader functional circuit supporting PI and the impact of Alzheimer's disease within it. This circuit includes orientation from head direction cells, landmark-based error correction, and signals encoding current or intended movement direction, which we suggest may rely on theta-modulated directional cells and theta sweeps in grid and place cell firing. The early vulnerability of PI, particularly angular PI, may reflect multiple sources: pathology in the anterodorsal thalamus degrading head direction coding; disrupted theta rhythmicity and thus theta-modulated directional signals, potentially reflecting cholinergic dysfunction; and retrosplenial landmark-resetting failures allowing angular drift. We advocate for further cross-species investigation of PI tasks with electrophysiological measures to fully identify the underlying circuit mechanisms and their impairment in Alzheimer's disease.

Indexed as

Alzheimer DiseaseOrientationTheta RhythmAnimalsHumansMovementAlzheimer's diagnosisangular path integrationcholinergic modulationdementiahead directiontheta rhythm

Identifiers

PMID41990387
PMCPMC7619079

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.